oncology
-
healthAI Achieves Expert-Level Accuracy in Early Gastric Cancer Detection
New AI models match expert endoscopists in diagnosing early gastric cancer from endoscopy images, signaling a significant advancement in early detection and patient outcomes.
-
healthGilead Acquires Arcellx for $7.8 Billion to Boost Cancer Therapy Pipeline
Gilead Sciences is acquiring Arcellx for $7.8 billion, aiming to fast-track its CAR-T cancer therapy for multiple myeloma and enhance its technology platform.
-
healthMetastatic Breast Cancer: Biomarker Differences Challenge Treatment
New research reveals significant biomarker heterogeneity in metastatic invasive lobular carcinoma, impacting treatment decisions and highlighting the need for comprehensive monitoring strategies.
-
healthPost-Diagnosis Exercise Slashes Cancer Mortality Risk
New research reveals physical activity after a cancer diagnosis significantly lowers mortality rates across multiple cancer types, even for previously inactive individuals.
-
healthCAR T Therapy: 4-1BB Design Dominates Leukemia Treatment
New meta-analysis reveals 4-1BB CAR T constructs offer superior efficacy and safety for relapsed B-cell acute lymphoblastic leukemia.
-
healthGenetic Obesity Risk Linked to Higher Breast Cancer Death Rates
New research reveals a genetic predisposition to higher body weight significantly increases mortality risk for breast cancer survivors, emphasizing personalized lifestyle interventions.
-
healthFocal Therapy Matches Surgery for Recurrent Prostate Cancer, With Fewer Complications
New study indicates salvage focal therapy offers comparable long-term cancer control to surgery for radiorecurrent prostate cancer, significantly reducing perioperative risks.
-
healthHead and Neck Cancer: Immunotherapy and Oncolytic Viruses Reshape Treatment
Explore the cutting edge of head and neck cancer treatment, focusing on immunotherapy and oncolytic viruses, with insights from leading oncologist Kevin Harrington.